Drugmakers Look for New Ways to Test Covid-19 Vaccines
As more Covid-19 vaccines become available in the U.S., it is getting tougher to run large clinical trials to test a new vaccine's ability to prevent disease because people are less willing to take a placebo--forcing drugmakers and researchers to look for workarounds as they vet the next generation of shots and test new uses for authorized ones.